Notch control of cell architecture: Potential implications for future cancer therapy

October 5, 2012
Notch control of cell architecture
Credit: Thinkstock

Dissecting the mechanisms implicated in cell architecture should provide new insights for understanding development and tissue morphogenesis in general. An European study focused on the role of the Notch signalling pathway in regulating cell architecture.

The Notch pathway is a cell communication pathway conserved throughout the animal kingdom and is implicated in various developmental processes as well as linked to many diseases including cancer. Apart from its role in control, the is believed to regulate the cytoskeleton and . However, the precise mechanism by which Notch exerts its effects on these processes remains elusive.

The 'Understanding Notch function in cell architecture regulation' (NOTCH AND CELL ARCH) proposal therefore aimed to identify and analyse new Notch involved in cell architecture regulation.

By performing a genome-wide analysis of Notch-regulated genes, it was possible to identify genes coding for key proteins involved in cell morphology. These were categorised according to whether they presented changes in expression or they were located in proximity to a genomic region occupied by the transcription factor Su(H) which is known to mediate Notch responses. This led to the identification of 30 potential Notch targets with function related to cell behaviour regulation.

The function of these targets was tested using assays based on and differentiation during oogenesis, myogenesis and formation of the Drosophila wing disc. Using the technology of (RNAi) to knock down gene expression, scientists identified nine genes whose depletion induced phenotypes associated with muscle formation defects, and two others (Moesin and Chickadee) that were required for the proper organisation of the wing disc.

The role of Notch in controlling the expression of cytoskeletal and cell behaviour regulators was also evaluated. Genomic analysis of three (Reck, Rhea/Talin and Trio) for Su(H) and Twist binding positions is expected to provide important information regarding the implication of Notch in their transcription regulation.

Overall, the outcomes of the NOTCH AND CELL ARCH project offered new knowledge on the role of the Notch signalling pathway in cell architecture. Given the importance of Notch signalling and cell organisation integrity in many cancers, these new identified factors might have important implications for future therapy.

Explore further: Scientists find new mechanism by which cell signaling pathway contributes to rheumatoid arthritis development

Related Stories

Scientists find new mechanism by which cell signaling pathway contributes to rheumatoid arthritis development

May 20, 2012
A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence ...

Penn researchers describe key molecule that keeps immune cell development on track

August 8, 2011
In the latest issue of Nature, researchers at the Perelman School of Medicine at the University of Pennsylvania clarify the role of two proteins key to T-cell development. They found that one well-known protein called Notch ...

Key growth factor identified in T cell leukemia

August 1, 2011
Blocking a growth factor receptor cripples cancer growth in a form of T cell leukemia, according to a study published online on August 1 in the Journal of Experimental Medicine.

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.